OptikosPrime and Eyewa Launch AI Eye Tests on Smartphones

A new partnership brings clinical-grade AI vision testing to the Middle East, allowing users to get prescriptions via mobile cameras.
Key points
- OptikosPrime and Eyewa have formed a strategic partnership to integrate AI vision diagnostics into eyewear retail.
- The system achieved a mean absolute error of less than 0.51 diopters in trials involving over 14,000 patients.
- The technology aims to reduce the barrier for the 2.2 billion people globally with vision impairment.
Buying glasses remains a friction-filled process for many consumers, often requiring appointments and visits to bulky optical equipment. To address this, Danish deep-tech firm OptikosPrime has partnered with Eyewa, the Middle East’s leading omnichannel eyewear retailer, to integrate AI-based vision diagnostics directly into the shopping experience.
The collaboration aims to replace the need for stationary, expensive optical rigs with a solution that uses standard smartphone cameras. According to Dataconomy, this shift allows customers to obtain full eyeglass prescriptions from a simple mobile photo, potentially reducing the high rate of online cart abandonment in the $190 billion global eyewear market.
Removing the Prescription Barrier
Eyewa’s Chief Optical Officer, François-Xavier Jombart, notes that uncertainty about prescriptions is the single biggest hurdle for customers seeking speed and simplicity. By embedding OptikosPrime’s Argus engine into both online and in-store channels, the retailer aims to turn this traditional barrier into an effortless step. This approach is designed to streamline the journey for shoppers who previously had to abandon their online carts to find a physical optometrist.
The technology also addresses a significant humanitarian gap. The World Health Organization reports that over one billion people have uncorrected vision impairment due to a lack of infrastructure and specialists. By enabling clinical-grade assessments on widely available devices, the partnership could make accurate vision care accessible to regions with fewer dedicated eye care facilities.
Validating Mobile Diagnostic Accuracy
Skepticism regarding mobile health diagnostics is common due to variables like hand shake and lighting conditions. OptikosPrime addressed these concerns through rigorous trials conducted with the NGO Sightsavers, evaluating over 14,000 patients across Africa and South Asia. The system demonstrated a mean absolute error of less than 0.51 diopters compared to high-end autorefractors, a level of accuracy that matches standard clinical benchmarks.
The algorithms are designed to compensate for spherical aberrations and device variability in real time. Independent validation from the Karolinska Institutet confirmed the robust performance of the system. This proven clinical rigor is a key factor in the technology's adoption, as it ensures that the convenience of smartphone testing does not come at the cost of diagnostic reliability.
Shifting from Hardware to Code
The partnership marks a transition from reliance on twenty-thousand-dollar stationary equipment to software-driven diagnostics. OptikosPrime spent five years developing the neural architecture that powers this shift, allowing optical diagnostics to move from heavy glass to light code. This model offers a scalable alternative to traditional infrastructure, particularly in areas where access to specialists is limited.






